Total Payments
$4,438
2023 Payments
$56.59
Companies
6
Transactions
24
Medicare Patients
5,560
Medicare Billing
$567,934
Payment Breakdown by Category
Consulting$2,763 (62.3%)
Travel$1,154 (26.0%)
Food & Beverage$521.40 (11.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,763 | 1 | 62.3% |
| Travel and Lodging | $1,154 | 5 | 26.0% |
| Food and Beverage | $521.40 | 18 | 11.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $4,108 | 11 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $145.72 | 2 | $0 (2022) |
| CSL Behring | $68.22 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $46.28 | 3 | $0 (2023) |
| ITI, Inc. | $39.49 | 2 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $29.51 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $56.59 | 3 | CSL Behring ($37.49) |
| 2022 | $167.80 | 4 | Janssen Pharmaceuticals, Inc ($124.01) |
| 2021 | $61.20 | 3 | ITI, Inc. ($39.49) |
| 2020 | $14.61 | 1 | CSL Behring ($14.61) |
| 2019 | $29.02 | 2 | CSL Behring ($16.12) |
| 2018 | $4,108 | 11 | AbbVie, Inc. ($4,108) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/12/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 07/20/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 03/14/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.10 | General |
| Category: Cardiovascular | ||||||
| 12/05/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/22/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Neuropsychiatry | ||||||
| 05/10/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Neuropsychiatry | ||||||
| 03/08/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| Category: Cardiovascular | ||||||
| 09/08/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: PSYCHIATRY | ||||||
| 08/12/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: PSYCHIATRY | ||||||
| 01/20/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/11/2020 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 06/12/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.90 | General |
| Category: Cardiovascular | ||||||
| 03/15/2019 | CSL Behring | Kcentra (Biological) | Food and Beverage | Cash or cash equivalent | $16.12 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 09/18/2018 | AbbVie, Inc. | Duopa (Drug) | Consulting Fee | Cash or cash equivalent | $2,762.50 | General |
| Category: Neuroscience | ||||||
| 09/18/2018 | AbbVie, Inc. | Duopa (Drug) | Travel and Lodging | In-kind items and services | $36.00 | General |
| Category: Neuroscience | ||||||
| 09/08/2018 | AbbVie, Inc. | Duopa (Drug) | Travel and Lodging | In-kind items and services | $646.74 | General |
| Category: Neuroscience | ||||||
| 09/08/2018 | AbbVie, Inc. | Duopa (Drug) | Travel and Lodging | In-kind items and services | $122.52 | General |
| Category: Neuroscience | ||||||
| 09/08/2018 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: Neuroscience | ||||||
| 09/08/2018 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Neuroscience | ||||||
| 09/08/2018 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: Neuroscience | ||||||
| 09/08/2018 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: Neuroscience | ||||||
| 09/07/2018 | AbbVie, Inc. | Duopa (Drug) | Travel and Lodging | In-kind items and services | $225.94 | General |
| Category: Neuroscience | ||||||
| 09/07/2018 | AbbVie, Inc. | Duopa (Drug) | Travel and Lodging | In-kind items and services | $122.52 | General |
| Category: Neuroscience | ||||||
| 09/07/2018 | AbbVie, Inc. | Duopa (Drug) | Food and Beverage | In-kind items and services | $120.52 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 1,503 | 1,560 | $1.5M | $148,906 |
| 2022 | 6 | 1,489 | 1,548 | $1.4M | $156,826 |
| 2021 | 5 | 1,242 | 1,279 | $1.0M | $129,251 |
| 2020 | 6 | 1,326 | 1,357 | $1.1M | $132,951 |
Total Patients
5,560
Total Services
5,744
Medicare Billing
$567,934
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 693 | 718 | $957,620 | $97,877 | 10.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 147 | 148 | $252,850 | $24,261 | 9.6% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 124 | 125 | $113,243 | $11,550 | 10.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 53 | $74,518 | $6,931 | 9.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 64 | 64 | $47,616 | $5,496 | 11.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 422 | 452 | $30,284 | $2,792 | 9.2% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 718 | 747 | $948,690 | $112,034 | 11.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 111 | 112 | $182,224 | $21,275 | 11.7% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 112 | 115 | $99,245 | $10,594 | 10.7% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 51 | 52 | $67,184 | $7,164 | 10.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 445 | 470 | $29,610 | $2,975 | 10.0% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 52 | 52 | $23,660 | $2,785 | 11.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 615 | 634 | $766,506 | $97,242 | 12.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 102 | 104 | $161,096 | $19,730 | 12.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 78 | 78 | $64,038 | $7,292 | 11.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 403 | 419 | $25,140 | $2,709 | 10.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 44 | 44 | $19,052 | $2,278 | 12.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 624 | 637 | $733,187 | $92,018 | 12.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 134 | 135 | $199,125 | $26,461 | 13.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 87 | 87 | $67,947 | $7,764 | 11.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 433 | 448 | $25,536 | $2,966 | 11.6% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 15 | 16 | $15,232 | $2,033 | 13.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 33 | 34 | $14,008 | $1,711 | 12.2% |
About Dr. Thomas Davis, M.D
Dr. Thomas Davis, M.D is a Emergency Medicine healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2014. The National Provider Identifier (NPI) number assigned to this provider is 1144648189.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Davis, M.D has received a total of $4,438 in payments from pharmaceutical and medical device companies, with $56.59 received in 2023. These payments were reported across 24 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($2,763).
As a Medicare-enrolled provider, Davis has provided services to 5,560 Medicare beneficiaries, totaling 5,744 services with total Medicare billing of $567,934. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Louisville, KY
- Active Since 04/06/2014
- Last Updated 07/21/2022
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1144648189
Products in Payments
- Duopa (Drug) $4,108
- XARELTO (Drug) $145.72
- Kcentra (Biological) $68.22
- CAPLYTA (Drug) $39.49
- INGREZZA (Drug) $29.51
- ELIQUIS (Drug) $27.18
- CAMZYOS (Drug) $19.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Louisville
Dr. Katherine Herold, M.d, M.D
Emergency Medicine — Payments: $7,802
Emergency Medicine $7,802
Judith Gladish, Aprn, APRN
Emergency Medicine — Payments: $6,091
Emergency Medicine $6,091
Daniel Danzl, Md, MD
Emergency Medicine — Payments: $4,734
Emergency Medicine $4,734
Dr. Martin Ozor, M.d, M.D
Emergency Medicine — Payments: $4,413
Emergency Medicine $4,413
Stephanie Dailey, M.d, M.D
Emergency Medicine — Payments: $2,947
Emergency Medicine $2,947
Dr. Thomas Pope, Md, MD
Emergency Medicine — Payments: $2,816
Emergency Medicine $2,816